Pharmaceutical Solvent Market: Ether Pharmaceutical Solvent Segment Projected to Register Significant CAGR over the Forecast Period: Global Industry Analysis and Opportunity Assessment, 2016-2026


  • Rep Id : XPLREP801
  • Published On : January, 2017
  • No. of Pages : 152
  • Category : Pharmaceutical
  • Publisher : Future Market Insights

Increasing growth of pharmaceutical and health care sectors in developing countries is fuelling the global pharmaceutical solvent market

The global pharmaceutical solvent market is expected to register a CAGR of 4.2% over the assessment period to account for US$ 4.1 Bn by 2026 end.

Global pharmaceutical solvent market analysis by Chemical Group

  • The Ether Pharmaceutical Solvent segment is projected to register a significant CAGR over the forecast period

  • The Ether pharmaceutical solvent segment is projected to gain 160 BPS between 2016 and 2026. This segment is estimated to register a CAGR of 5.5% over the forecast period, expected to reach up to US$ 699.2 Mn by the end of 2026

  • The growing demand for dimethyl ether and polyethylene glycol is expected to boost the demand in the ether pharmaceutical segment

  • The Others pharmaceutical solvent segment is expected to lose 100 BPS over the projected period

  • The Others segment is expected to register a CAGR of 4.0% over the forecast period. This segment is expected to reach up to US$ 1,023 Mn by the end of 2026

  • The Ether pharmaceutical segment is expected to expand in the first half over the forecast period and is expected to have stable growth in the global pharmaceutical solvent market

  • The Alcohol pharmaceutical solvent segment is expected to account for the maximum share in the global pharmaceutical solvent market, registering an estimated CAGR of 4.5%

  • The Chlorinated Solvents segment is expected to expand in second half with an estimated CAGR of 3.5% over the forecast period

  • The Ester pharmaceutical segment is expected to have stable growth in the global pharmaceutical solvent market expanding with an estimated CAGR of 4.0% over the forecast period

  • The Alcohol pharmaceutical solvent segment is expected to create high value opportunity over the forecast period

  • The Alcohol pharmaceutical solvent segment is expected to register an estimated CAGR of 4.5% over the forecast period. This segment is expected to create total incremental opportunity of US$ 541 Mn between 2016 and 2026

  • The Others pharmaceutical solvent segment is expected to create high value opportunity over the forecast period

  • The Chlorinated Solvents segment is expected to register an estimated CAGR of 3.5% over the forecast period reaching up to US$ 52.3 Mn by the end of 2016. This segment is expected to create total incremental opportunity of US$ 21 Mn between 2016 and 2026

  • The Others pharmaceutical solvent segment is expected to register an estimated CAGR of 4% over the forecast period, reaching up to US$ 1023 Mn by the end of 2026. This segment is expected to create total incremental opportunity of US$ 334 Mn between 2016 and 2026

  • The Ester pharmaceutical segment is expected to gain maximum attractiveness over the assessment period

  • The Ester pharmaceutical solvent segment is expected to gain maximum market attractiveness between 2016 and 2026. This segment is expected to expand with an estimated CAGR of 4.0% over the forecast period, reaching up to US$ 640.6 Mn by the end of 2026

  • Growing demand for ethyl acetate is expected to fuel the demand of the Ester pharmaceutical solvent segment. Ethyl acetate is expected to register an estimated CAGR of 4.6% over the forecast period

  • The Ether pharmaceutical solvent segment is expected to gain attractiveness between 2016 and 2026, and is anticipated to hold a market share of 16.7% in the global pharmaceutical solvent market